Chemring Drops as Contract Delays Lead to Lower Forecast

Chemring Group Plc, the target of a takeover approach by Carlyle Group LLP, fell the most in more than 15 years after delays in Middle Eastern sales and a new countermeasures product led to a profit-forecast cut.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.